共 307 条
[1]
Oettle H(2007)Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA. 297 267-77
[2]
Post S(2007)Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume Cancer 110 1227-34
[3]
Neuhaus P(2012)Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy Ann. Surg. Oncol. 19 2045-53
[4]
Gellert K(2014)Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract 18 16-24-25
[5]
Langrehr J(2007)Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J. Am. Coll. Surg. 204 347-55
[6]
Ridwelski K(2015)Neoadjuvant therapy for localized pancreatic cancer: guiding principles J. Gastrointest. Oncol. 6 418-29
[7]
Bilimoria KY(2014)Neoadjuvant therapy for pancreas cancer: past lessons and future therapies World J. Gastroenterol. 20 15564-79
[8]
Bentrem DJ(1980)Preoperative irradiation in carcinoma of the pancreas Cancer. 46 1945-9
[9]
Ko CY(2008)Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial Am. J. Clin. Oncol. 31 545-52
[10]
Tomlinson JS(2008)Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 26 3496-502